| Autor: |
Nolan E; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Bridgeman VL; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Ombrato L; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK.; Barts Cancer Institute, Queen Mary University of London, London, UK., Karoutas A; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Rabas N; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Sewnath CAN; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Vasquez M; Cancer Immunology Unit, UCL Cancer Institute, University College London, London, UK., Rodrigues FS; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Horswell S; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Faull P; Proteomics Unit, The Francis Crick Institute, London, UK.; Center for Biomedical Research Support Biological Mass Spectrometry Facility, The University of Texas at Austin, Austin, TX, USA., Carter R; Preclinical Radiotherapy TTP, CRUK-City of London Centre, UCL Cancer Institute, University College London, London, UK., Malanchi I; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK. Ilaria.Malanchi@crick.ac.uk. |
Full text from SpringerLink